GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Interest Expense

Camurus AB (FRA:7CA) Interest Expense : €-0.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Camurus AB's interest expense for the three months ended in Mar. 2024 was € -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Camurus AB's Operating Income for the three months ended in Mar. 2024 was € 7.0 Mil. Camurus AB's Interest Expense for the three months ended in Mar. 2024 was € -0.0 Mil. Camurus AB's Interest Coverage for the quarter that ended in Mar. 2024 was 278.04. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Camurus AB Interest Expense Historical Data

The historical data trend for Camurus AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Interest Expense Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -0.15 -0.13 -0.11 -0.11

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.03 -0.03 -0.03

Camurus AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB  (FRA:7CA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Camurus AB's Interest Expense for the three months ended in Mar. 2024 was €-0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was €7.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €1.1 Mil.

Camurus AB's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*6.951/-0.025
=278.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Camurus AB has enough cash to cover all of its debt. Its financial situation is stable.


Camurus AB (FRA:7CA) Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines